Founded in 1961, Advanced BioScience Laboratories (ABL) is a contract research organization (CRO) and contract development and manufacturing organization (CDMO) with a strong core of product development expertise, GMP manufacturing, and immunological testing capabilities. We partner with our clients to support advancement of their candidate vaccines and therapeutics through preclinical and clinical development. As a comprehensive Immunology CRO, our services encompass the full scope of immunological response to support advancement of therapeutics and vaccines from discovery through preclinical and clinical development. Through our work over the years, ABL has developed a broad range of Immunological, virological and PCR-based assays across multiple platforms to support preclinical and clinical studies for a variety of indications and treatments, including infectious diseases, oncology, neurodegenerative disorders, and cell & gene therapies. ABL is a subsidiary of the Institut Mérieux, with sites in France and the United States.
Focus Areas